Katherine Dacey

Goodwin

Contact
View Bio
RSS

Latest Posts › Corporate Counsel

Share:

2022 Year in Review: Securities Litigation Against Life Sciences Companies

We are proud to present our seventh annual Securities Litigation Year in Review publication, in which we analyze data for securities class actions filed nationally against publicly traded pharmaceutical, biotechnology,...more

3/6/2023  /  Appellate Courts , Biotechnology , Class Action , Corporate Counsel , Life Sciences , Pharmaceutical Industry , Securities , Securities and Exchange Commission (SEC) , Securities Litigation , Securities Regulation
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide